Please Wait.....
Report
Autoinjectors Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Disposable Auto-injectors, Reusable Auto-injectors {Prefilled, Empty}), By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other), By End User (Homecare Settings, Hospitals & Clinics, Ambulatory Surgical Centers), By Region & Competition, 2020-2030F
Market Report I 2025-06-13 I 180 Pages I TechSci Research
Market Overview
The Global Autoinjectors Market was valued at USD 9.15 Billion in 2024 and is projected to reach USD 20.43 Billion by 2030, growing at a CAGR of 14.28%. Autoinjectors are advanced drug delivery devices designed for easy and safe self-administration of medications, particularly for chronic and emergency conditions. These devices are increasingly used across therapeutic areas such as diabetes, autoimmune diseases, and anaphylaxis, offering convenience and accuracy without the need for medical supervision. The market's growth is propelled by the global shift toward patient-centric care and the rising preference for home-based treatment options. Autoinjectors improve treatment adherence through features such as ergonomic designs, concealed needles, and pre-measured doses. As healthcare systems emphasize value-based care, autoinjectors are gaining traction for reducing hospital dependency and enhancing clinical outcomes. The market also benefits from pharmaceutical innovation focused on pairing biologics with user-friendly delivery systems, supporting the trend of self-managed therapies and broadening the adoption of autoinjectors globally.
Key Market Drivers
Rising Prevalence of Chronic and Autoimmune Diseases
The growing incidence of chronic and autoimmune diseases is a primary factor driving demand for autoinjectors. Conditions such as diabetes, rheumatoid arthritis, and multiple sclerosis are on the rise due to aging populations, lifestyle changes, and better diagnostics. For example, global diabetes prevalence is expected to increase from 537 million adults in 2024 to 643 million by 2030. These conditions often require long-term injectable therapies, making autoinjectors an effective solution for regular, accurate self-administration. By minimizing the complexity of injections and reducing the need for clinic visits, autoinjectors help patients maintain consistent treatment schedules, thereby improving health outcomes and adherence. Their ease of use also reduces the risk of dosage errors and needle anxiety. As healthcare systems aim to reduce costs and improve quality through better disease management, autoinjectors have become integral to chronic care strategies, further strengthening their market growth.
Key Market Challenges
High Manufacturing and Development Costs
Developing and producing autoinjectors involves significant investment due to their design complexity and regulatory requirements. These devices must meet stringent safety, compatibility, and performance standards, particularly when paired with biologics. Processes such as stability testing, risk analysis, and ensuring device-drug integration contribute to high R&D expenditures. Smaller pharmaceutical and biotech firms without in-house manufacturing capabilities often face financial barriers to market entry. Customization demands for different therapeutic areas and regions, as well as integration of digital features for monitoring, further increase development costs. These challenges are especially pronounced in developing regions where pricing pressure limits widespread adoption. The capital-intensive nature of the autoinjector segment remains a major constraint on scalability and profitability for emerging market players.
Key Market Trends
Shift Toward Home-Based and Self-Administered Treatment Models
A key trend transforming the autoinjectors market is the growing emphasis on home-based healthcare. Patients managing long-term conditions are increasingly seeking alternatives to frequent clinical visits. Autoinjectors support this shift by allowing individuals to self-administer medication safely and efficiently. Their user-friendly design, automatic needle retraction, and preset dosing mechanisms reduce the risk of misuse and improve adherence. This aligns with healthcare strategies aimed at lowering costs, reducing hospital load, and empowering patients. Pharmaceutical companies are responding by developing drugs compatible with autoinjector formats, thereby extending product lifecycles and enhancing market reach. As patient education and digital health adoption grow, autoinjectors are poised to become a standard component of modern chronic disease management and at-home care models.
Key Market Players
- Eli Lilly and Company
- SHL Medical AG
- AbbVie Inc
- Amgen Inc
- Owen Mumford Limited
- Ypsomed AG
- Teva Pharmaceutical Industries Ltd
- Biogen Inc.
- Viatris Inc
- Pfizer, Inc.
- Gerresheimer AG
Report Scope:
In this report, the Global Autoinjectors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Autoinjectors Market, By Product:
o Disposable Auto-injectors
o Reusable Auto-injectors
- Autoinjectors Market, By Indication:
o Rheumatoid Arthritis
o Multiple Sclerosis
o Diabetes
o Anaphylaxis
o Other
- Autoinjectors Market, By End User:
o Homecare Settings
o Hospitals & Clinics
o Ambulatory Surgical Centers
- Autoinjectors Market, By Region:
o North America
United States
Canada
Mexico
o Europe
France
United Kingdom
Italy
Germany
Spain
o Asia-Pacific
China
India
Japan
Australia
South Korea
o South America
Brazil
Argentina
Colombia
o Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Autoinjectors Market.
Available Customizations:
Global Autoinjectors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Autoinjectors Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Disposable auto-injectors, Reusable auto-injectors {Prefilled, Empty})
5.2.2. By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other)
5.2.3. By End User (Homecare Settings, Hospitals & Clinics, Ambulatory Surgical Centers)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Autoinjectors Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Indication
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Autoinjectors Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Indication
6.3.1.2.3. By End User
6.3.2. Canada Autoinjectors Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Indication
6.3.2.2.3. By End User
6.3.3. Mexico Autoinjectors Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Indication
6.3.3.2.3. By End User
7. Europe Autoinjectors Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Indication
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Autoinjectors Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Indication
7.3.1.2.3. By End User
7.3.2. United Kingdom Autoinjectors Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Indication
7.3.2.2.3. By End User
7.3.3. Italy Autoinjectors Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Indication
7.3.3.2.3. By End User
7.3.4. France Autoinjectors Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Indication
7.3.4.2.3. By End User
7.3.5. Spain Autoinjectors Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Indication
7.3.5.2.3. By End User
8. Asia-Pacific Autoinjectors Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Indication
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Autoinjectors Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Indication
8.3.1.2.3. By End User
8.3.2. India Autoinjectors Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Indication
8.3.2.2.3. By End User
8.3.3. Japan Autoinjectors Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Indication
8.3.3.2.3. By End User
8.3.4. South Korea Autoinjectors Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Indication
8.3.4.2.3. By End User
8.3.5. Australia Autoinjectors Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Indication
8.3.5.2.3. By End User
9. South America Autoinjectors Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Indication
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Autoinjectors Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Indication
9.3.1.2.3. By End User
9.3.2. Argentina Autoinjectors Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Indication
9.3.2.2.3. By End User
9.3.3. Colombia Autoinjectors Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Indication
9.3.3.2.3. By End User
10. Middle East and Africa Autoinjectors Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Indication
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Autoinjectors Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Indication
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Autoinjectors Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Indication
10.3.2.2.3. By End User
10.3.3. UAE Autoinjectors Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Indication
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Autoinjectors Market: SWOT Analysis
14. Competitive Landscape
14.1. Eli Lilly and Company
14.1.1. Business Overview
14.1.2. Product & Service Offerings
14.1.3. Recent Developments
14.1.4. Financials (If Listed)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. SHL Medical AG
14.3. AbbVie Inc
14.4. Amgen Inc
14.5. Owen Mumford Limited
14.6. Ypsomed AG
14.7. Teva Pharmaceutical Industries Ltd
14.8. Biogen Inc.
14.9. Viatris Inc
14.10.Pfizer, Inc.
14.11.Gerresheimer AG
15. Strategic Recommendations
16. About Us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security